Kidney Cancer

>

Latest News

Personalized kidney cancer vaccines may help guide immune therapies to more effectively attack cancerous cells while mitigating harm to healthy tissue.
Personalized Cancer Vaccines May Transform Treatment Options in Kidney Cancer

July 25th 2025

Personalized kidney cancer vaccines may help guide immune therapies to more effectively attack cancerous cells while mitigating harm to healthy tissue.

Collaborators in the Kidney Cancer Research Consortium aim to address mechanistic and scientifically driven questions in the kidney cancer field.
Research Consortium Aims to Accelerate Progress in Kidney Cancer Management

July 25th 2025

A genitourinary oncologist explained that KIM-1 can be used diagnose, risk-stratify, detect, and monitor disease treatment in patients with kidney cancers.
Analyzing Natural Killer Cell Restoration/KIM-1 Biomarker in Kidney Cancer

July 24th 2025

Neoantigen Vaccines Are Leading to a Personalized Frontier in RCC Immunotherapy
Neoantigen Vaccines Are Leading to a Personalized Frontier in RCC Immunotherapy

July 20th 2025

CAR T-Cell Therapy to Target CAIX/CD70 Overexpression in ccRCC
CAR T-Cell Therapy to Target CAIX/CD70 Overexpression in ccRCC

July 19th 2025

Video Series
Video Interviews
Podcasts
Two oncologists discuss the impact of advocacy in kidney cancer research, highlighting collaboration between researchers, advocates, and physicians.
Experts discuss findings related to liquid biopsy profiling, later-line immunotherapy, and CDK4/6 inhibitor efficacy presented at the 2024 KCRS meeting.
Santosh Rao, MD, discusses the formation of new guidelines informing the use of integrative oncology for patients with kidney cancer from the Society for Integrative Oncology.

More News